Oral Drug Delivery Resources

  1. The Role Of Micronization In The Journey To Drug Product Development

    Micronization is an incredibly important step of the process of transitioning a compound from initial discovery into the clinic. Learn more about the key benefits of micronization.

  2. Solutions For Accelerated Pharmaceutical Development

    Explore an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties such as low aqueous solubility and poor bioavailability.

  3. Choosing A Formulation And Process Approach To OCR Products 11/5/2018

    Do you want to develop an oral controlled release (OCR) product? Understand the options and their ramifications as the first step toward devising a plan.

  4. Solutions For Challenging Compounds Using Softgel Innovation 5/5/2017

    The significant interest in semi-solid systems for the potential of extended release profiles has prompted researchers to develop alternative encapsulating systems. 

  5. Rational Design Of Oral Nanosuspensions For Insoluble Drugs 1/26/2022

    The advantages of nanosuspension dosage forms include improving bioavailability and API stability, increasing drug loading, better dose flexibility and accuracy, and easy swallowing for pediatric or geriatric populations.

  6. From Nanoformed Powder To 3D Printable Ink 3/22/2023

    3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials.

  7. Formulation Development Strategy For Early Phase Human Studies 1/27/2022

    Determining bioavailable formulation for animal PK, GLP toxicity, first-in-human, and first-in-patient is challenging. Drug delivery systems are usually used for poorly soluble and bioavailable compounds.

  8. Patient-Centric Solutions To Optimize Medication Adherence

    Explore how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.

  9. A New Framework For Identifying Nitrosamine Risks And Derisking Products 6/18/2024

    Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

  10. The Secrets Of A Successful CDMO Partnership 6/30/2025

    From managing supply chain disruptions to maintaining a strong customer-first culture, Steven Selling offers a candid look at the strategies that help turn operational challenges into shared success.